Accelerated partial breast irradiation: The need for well-defined patient selection criteria, improved volume definitions, close follow-up and discussion of salvage treatment

Breast

Volumn 21, Issue 6, 2012, Pages 707-715

  Moser, Elizabeth C ^a   Vrieling, Conny ^b  

^a Champalimaud Cancer Centre   (Portugal)

^b Centre d'Oncologie des Eaux Vives   (Switzerland)

Author keywords

Accelerated partial breast irradiation; External beam radiotherapy; Interstitial brachytherapy; Intra cavitary brachytherapy; Intra operative radiotherapy; Patient selection guidelines; Permanent seed implant; Salvage treatment after partial breast irradiation; Whole breast radiotherapy

Indexed keywords

ACCELERATED PARTIAL BREAST IRRADIATION; BRACHYTHERAPY; BRACHYTHERAPY DEVICE; BREAST CANCER; CANCER RADIOTHERAPY; ELECTRON THERAPY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INTERSTITIAL BRACHYTHERAPY; INTRACAVITY BRACHYTHERAPY; INTRAOPERATIVE RADIOTHERAPY; MASTECTOMY; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REVIEW; SALVAGE THERAPY; TUMOR VOLUME;

EID: 84869207683     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2012.09.014     Document Type: Review

References (131)

1. Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
2. Litière S., Werutsky G., Fentiman I.S., Rutgers E., Christiaens M.R., Van Limbergen E., et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 2012, 13:412-419.
3. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New Engl J Med 2002, 347:1233-1241.
4. Veronesi U., Cascinelli N., Mariani L., Greco M., Saccozzi R., Luini A., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New Engl J Med 2002, 347:1227-1232.
5. Vinh-Hung V., Voordeckers M., Van de Steene J., Soete G., Lamote J., Storme G. Omission of radiotherapy after breast-conserving surgery: survival impact and time trends. Radiother Oncol 2003, 67:147-158.
6. Darby S., McGale P., Correa C., Taylor C., Arriagada R., et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011, 378:1707-1716. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
7. Recht A., Solin L.J. Breast-conserving surgery and radiotherapy in early-stage breast cancer: the importance of local control. Semin Radiat Oncol 2011, 21:3-9.
8. Nattinger A.B. Variation in the choice of breast-conserving surgery or mastectomy: patient or physician decision making?. J Clin Oncol 2005, 23:5429-5431.
9. Schroen A.T., Brenin D.R., Kelly M.D., Knaus W.A., Slingluff C.L. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol 2005, 23:7074-7080.
10. Hershman D.L., Buono D., McBride R.B., Tsai W.Y., Joseph K.A., Grann V.R., et al. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst 2008, 100:199-206.
11. Athas W.F., Adams-Cameron M., Hunt W.C., Amir-Fazli A., Key C.R. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 2000, 92:269-271.
12. Fong A., Shafiq J., Saunders C., Thompson A.M., Tyldesley S., Olivotto I.A., et al. A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy. Breast 2012, 21:570-577.
13. Holland R., Veling S.H., Mravunac M., Hendriks J.H. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985, 56:979-990.
14. McCormick B., Kinne D., Petrek J., Osborne M., Cox L., Shank B., et al. Limited resection for breast cancer: a study of inked specimen margins before radiotherapy. Int J Radiat Oncol Biol Phys 1987, 13:1667-1671.
15. Gurdal S.O., Karanlik H., Cabioglu N., Ozcinar B., Yavuz E., Tuzlali S., et al. Positive or close margins in breast conserving surgery: is re-excision always necessary?. Eur J Surg Oncol 2012, 38:399-406.
16. Vaidya J.S., Vyas J.J., Chinoy R.F., Merchant N., Sharma O.P., Mittra I. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer 1996, 74:820-824.
17. Goldstein S.N. Controversies in pathology in early-stage breast cancer. Semin Radiat Oncol 2011, 21:20-25.
18. Vinh-Hung V., Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 2004, 96:115-121.
19. Fisher E.R. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast. CA Cancer J Clin 1997, 47:52-64.
20. van de Water W., Markopoulos C., van de Velde C.J., Seynaeve C., Hasenburg A., Rea D., et al. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 2012, 307:590-597.
21. Nguyen P.L., Taghian A.G., Katz M.S., Niemierko A., Abi Raad R.F., Boon W.L., et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 2008, 26:2373-2378. Erratum in: J Clin Oncol 2008; 26: 3110.
22. Jones H.A., Antonini N., Hart A.A., Peterse J.L., Horiot J.C., Collin F., et al. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J Clin Oncol 2009, 27:4939-4947.
23. Peiro G., Bornstein B.A., Connolly J.L., Gelman R., Hetelekidis S., Nixon A.J., et al. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 2000, 59:49-54.
24. Arvold N.D., Taghian A.G., Niemierko A., Abi Raad R.F., Sreedhara M., Nguyen P.L., et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol 2011, 29:3885-3891.
25. Ali A.N., Vapiwala N., Guo M., Hwang W.T., Harris E.E., Solin L.J. The impact of re-excision and residual disease on local recurrence after breast conservation treatment for patients with early stage breast cancer. Clin Breast Cancer 2011, 11:400-405.
26. MacDonald S., Taghian A.G. Prognostic factors for local control after breast conservation: does margin status still matter?. J Clin Oncol 2009, 27:4929-4930.
27. ® local-regional recurrence (LR) and salvage surgery: breast cancer. Am J Clin Oncol 2012, 35:178-182.
28. Njeh C.F., Saunders M.W., Langton C.M. Accelerated partial breast irradiation (APBI): a review of available techniques. Radiat Oncol 2010, 5:90.
29. Sanders M.E., Scroggins T., Ampil F.L., Li B.D. Accelerated partial breast irradiation in early-stage breast cancer. J Clin Oncol 2007, 25:996-1002.
30. Biagioli M.C., Harris E.E. Accelerated partial breast irradiation: potential roles following breast-conserving surgery. Cancer Control 2010, 17:191-204.
31. Lehman M., Hickey B. The less than whole breast radiotherapy approach. Breast 2010, 19:180-187.
32. Lievens Y. Hypofractionated breast radiotherapy: financial and economic consequences. Breast 2010, 19:192-197.
33. Polgár C., Major T., Fodor J., Németh G., Orosz Z., Sulyok Z., et al. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 2004, 60:1173-1181.
34. Chen P.Y., Vicini F.A., Benitez P., Kestin L.L., Wallace M., Mitchell C., et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 2006, 106:991-999.
35. Johansson B., Karlsson L., Liljegren G., Hardell L., Persliden J. Pulse dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1-T2 breast cancer: first long term results from a clinical study. Radiother Oncol 2009, 90:30-35.
36. Kaufman S.A., DiPetrillo T.A., Price L.L., Midle J.B., Wazer D.E. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer. Brachytherapy 2007, 6:286-292.
37. Arthur D.W., Winter K., Kuske R.R., Bolton J., Rabinovitch R., White J., et al. A phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys 2008, 72:467-473.
38. Ott O.J., Hildebrandt G., Pötter R., Hammer J., Lotter M., Resch A., et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol 2007, 82:281-286.
39. Yoshida K., Nose T., Masuda N., Yamazaki H., Kotsuma T., Yoshida M., et al. Preliminary result of accelerated partial breast irradiation after breast-conserving surgery. Breast Cancer 2009, 16:105-112.
40. Aristei C., Palumbo I., Cucciarelli F., Cavalli A., Tarducci R., Raymondi C., et al. Partial breast irradiation with interstitial high-dose-rate brachytherapy in early breast cancer: results of a phase II prospective study. Eur J Surg Oncol 2009, 35:144-150.
41. Lawenda B.D., Taghian A.G., Kachnic L.A., Hamdi H., Smith B.L., Gadd M.A., et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 2003, 56:671-680.
42. Benitez P.R., Keisch M.E., Vicini F., Stolier A., Scroggins T., Walker A., et al. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 2007, 194:456-462.
43. Chao K.K., Vicini F.A., Wallace M., Mitchell C., Chen P., Ghilezan M., et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the William Beaumont Hospital experience. Int J Radiat Oncol Biol Phys 2007, 69:32-40.
44. Belkacémi Y., Chauvet M.P., Giard S., Villette S., Lacornerie T., Bonodeau F., et al. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. Radiother Oncol 2009, 90:23-29.
45. Vicini F., Beitsch P., Quiet C., Gittleman M., Zannis V., Fine R., et al. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2011, 79:808-817.
46. Dickler A., Ivanov O., Francescatti D. Intraoperative radiation therapy in the treatment of early-stage breast cancer utilizing Xoft Axxent electronic brachytherapy. World J Surg Oncol 2009, 7:24.
47. Ivanov O., Dickler A., Lum B.Y., Pellicane J.V., Francescatti D.S. Twelve-month follow-up results of a trial utilizing Axxent electronic brachytherapy to deliver intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol 2011, 18:453-458.
48. Dickler A., Patel R.R., Wazer D. Breast brachytherapy devices. Expert Rev Med Devices 2009, 6:325-333.
49. Strauss J.B., Dickler A. Accelerated partial breast irradiation utilizing balloon brachytherapy techniques. Radiother Oncol 2009, 91:157-165.
50. Veronesi U., Orecchia R., Luini A., Galimberti V., Zurrida S., Intra M., et al. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat 2010, 124:141-151.
51. Vaidya J.S., Joseph D.J., Tobias J.S., Bulsara M., Wenz F., Saunders C., et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 2010, 376:91-102.
52. Vaidya J.S., Baum M., Tobias J.S., Wenz F., Massarut S., Keshtgar M., et al. Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery. Int J Radiat Oncol Biol Phys 2011, 81:1091-1097.
53. Sautter-Bihl M.L., Sedlmayer F., Budach W., Dunst J., Engenhart-Cabillic R., Fietkau R., et al. Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer: beware of one-stop shops?. Strahlenther Onkol 2010, 186:651-657.
54. Anderson B.O., Masetti R., Silverstein M.J. Oncoplastic approaches to partial mastectomy: an overview of volume-displacement techniques. Lancet Oncol 2005, 6:145-157.
55. Njeh C.F., Saunders M.W., Langton C.M. Accelerated partial breast irradiation using external beam conformal radiation therapy: a review. Crit Rev Oncol Hematol 2012, 81:1-20.
56. Taghian A.G., Alm El-Din M., Smith B.L. Interim results of a phase I/II trial of 3D-conformal external beam accelerated partial breast irradiation in patients with early breast cancer. Int J Radiat Oncol Biol Phys 2008, 72:S4.
57. Patel R.R., Becker S.J., Das R.K., Mackie T.R. A dosimetric comparison of accelerated partial breast irradiation techniques: multicatheter interstitial brachytherapy, three-dimension conformal radiotherapy, and supine versus prone helical tomotherapy. Int J Radiat Oncol Biol Phys 2007, 68:935-942.
58. Formenti S.C., Gidea-Addeo D., Goldberg J.D., Roses D.F., Guth A., et al. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol 2007, 25:2236-2242.
59. Vicini F., Winter K., Wong J., Pass H., Rabinovitch R., Chafe S., et al. Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys 2010, 77:1120-1127.
60. Chen P.Y., Gustafson G.S., Mitchell C., Wallace M., Hasan Y., Martinez A.A., et al. Three-year clinical experience utilizing 3D-conformal radiation therapy to deliver accelerated partial breast irradiation (APBI). Int J Radiat Oncol Biol Phys 2008, 72:S3-S4.
61. Lewin A.A., Derhagopian R., Saigal K., Panoff J.E., Abitbol A., Wieczorek D.J., et al. Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer. Int J Radiat Oncol Biol Phys 2012, 82:2104-2110.
62. Reynders T., Tournel K., De Coninck P., Heymann S., Vinh-Hung V., Van Parijs H., et al. Dosimetric assessment of static and helical TomoTherapy in the clinical implementation of breast cancer treatments. Radiother Oncol 2009, 93:71-79.
63. Prionas N.D., McKenney S.E., Stern R.L., Boone J.M. Kilovoltage rotational external beam radiotherapy on a breast computed tomography platform: a feasibility study. Int J Radiat Oncol Biol Phys 2012, 84(2):533-539.
64. Kozak K.R., Smith B.L., Adams J., Kornmehl E., Katz A., Gadd M., et al. Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys 2006, 66:691-698.
65. Keller B., Sankreacha R., Rakovitch E., O'brien P., Pignol J.P. A permanent breast seed implant as partial breast radiation therapy for early-stage patient: a comparison of palladium-103 and iodine-125 isotopes based on radiation safety considerations. Int J Radiat Oncol Biol Phys 2005, 62:358-365.
66. Jansen N., Deneufbourg J.M., Nickers P. Adjuvant stereotactic permanent seed breast implant: a boost series in view of partial breast irradiation. Int J Radiat Oncol Biol Phys 2007, 67:1052-1058.
67. 103Pd permanent breast seed implants. Phys Med Biol 2012, 57:809-823.
68. Wilson M., Korourian S., Boneti C., Adkins L., Badgwell B., Lee J., et al. Long-term results of excision followed by radiofrequency ablation (eRFA) as the sole local therapy for breast cancer 2012, ASBrS, Abstract 136.
69. Smith B.D., Arthur D.W., Buchholz T.A., Haffty B.G., Hahn C.A., Hardenbergh P.H., et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009, 74:987-1001.
70. Polgár C., Van Limbergen E., Pötter R., Kovács G., Polo A., Lyczek J., et al. GEC-ESTRO breast cancer working group. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence. Radiother Oncol 2009, 2010(94):264-273.
71. Ott O.J., Hildebrandt G., Pötter R., Hammer J., Hindemith M., Resch A., et al. Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence. Int J Radiat Oncol Biol Phys 2011, 80:1458-1463.
72. Park C.C., Mitsumori M., Nixon A., Recht A., Connolly J., Gelman R., et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000, 18:1668-1675.
73. Abdulkarim B.S., Cuartero J., Hanson J., Deschênes J., Lesniak D., Sabri S. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. J Clin Oncol 2011, 29:2852-2858.
74. Demirci S., Broadwater G., Marks L.B., Clough R., Prosnitz L.R. Breast conservation therapy: the influence of molecular subtype and margins. Int J Radiat Oncol Biol Phys 2012, 83:814-820.
75. Hattangadi-Gluth J.A., Wo J.Y., Nguyen P.L., Abi Raad R.F., Sreedhara M., Niemierko A., et al. Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. Int J Radiat Oncol Biol Phys 2012, 82:1185-1191.
76. Kreike B., Halfwerk H., Armstrong N., Bult P., Foekens J.A., Veltkamp S.C., et al. Local recurrence after breast-conserving therapy in relation to gene expression patterns in a large series of patients. Clin Cancer Res 2009, 15:4181-4190.
77. Vicini F.A., Antonucci J.V., Wallace M., Gilbert S., Goldstein N.S., Kestin L., et al. Long-term efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation. Int J Radiat Oncol Biol Phys 2007, 68:341-346.
78. Niméus-Malmström E., Krogh M., Malmström P., Strand C., Fredriksson I., Karlsson P., et al. Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy. Breast Cancer Res 2008, 10:R34.
79. Sanghani M., Truong P.T., Raad R.A., Niemierko A., Lesperance M., Olivotto I.A., et al. Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol 2010, 28:718-722.
80. Werkhoven E., Hart G., Tinteren H., Elkhuizen P., Collette L., Poortmans P., et al. Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial. Radiother Oncol 2011, 100:101-107.
81. Patel R.R., Christensen M.E., Hodge C.W., Adkison J.B., Das R.K. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results. Int J Radiat Oncol Biol Phys 2008, 70:970-973.
82. Shaitelman S.F., Vicini F.A., Beitsch P., Haffty B., Keisch M., Lyden M. Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry Trial. Cancer 2010, 116:4677-4685.
83. Wolmark N, Curran WJ, Vicini F, et al. NSABP protocol B-39. RTOG protocol 0413. A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. Available from: http://www.rtog.org/members/protocols/0413.
84. Moon H.J., Kim M.J., Kwak J.Y., Kim E.K. Probably benign breast lesions on ultrasonography: a retrospective review of ultrasonographic features and clinical factors affecting the BI-RADS categorization. Acta Radiol 2010, 51:375-382.
85. Orel S. Who should have breast magnetic resonance imaging evaluation?. J Clin Oncol 2008, 26:703-711.
86. Deurloo E.E., Muller S.H., Peterse J.L., Besnard A.P., Gilhuijs K.G. Clinically and mammographically occult breast lesions on MR images: potential effect of computerized assessment on clinical reading. Radiology 2005, 234:693-701.
87. Gutierrez R.L., DeMartini W.B., Silbergeld J.J., Eby P.R., Peacock S., et al. High cancer yield and positive predictive value: outcomes at a center routinely using preoperative breast MRI for staging. AJR Am J Roentgenol 2011, 196:W93-W99.
88. Al-Hallaq H.A., Mell L.K., Bradley J.A., Chen L.F., Ali A.N., Weichselbaum R.R., et al. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer 2008, 113:2408-2414.
89. Kühr M., Wolfgarten M., Stölzle M., Leutner C., Höller T., Schrading S., et al. Potential impact of preoperative magnetic resonance imaging of the breast on patient selection for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2011, 81:e541-546.
90. Landis D.M., Luo W., Song J., Bellon J.R., Punglia R.S., Wong J.S., et al. Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int J Radiat Oncol Biol Phys 2007, 67:1299-1308.
91. Benda R.K., Yasuda G., Sethi A., Gabram S.G., Hinerman R.W., Mendenhall N.P. Breast boost: are we missing the target?. Cancer 2003, 97:905-909.
92. Dzhugashvili M., Tournay E., Pichenot C., Dunant A., Pessoa E., Khallel A., et al. 3D-conformal accelerated partial breast irradiation treatment planning: the value of surgical clips in the delineation of the lumpectomy cavity. Radiat Oncol 2009, 4:70.
93. Weed D.W., Yan D., Martinez A.A., Vicini F.A., Wilkinson T.J., Wong J. The validity of surgical clips as a radiographic surrogate for the lumpectomy cavity in image-guided accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2004, 60:484-492.
94. Jobsen J.J., van der Palen J., Ong F. Effect of external boost volume in breast-conserving therapy on local control with long-term follow-up. Int J Radiat Oncol Biol Phys 2008, 71:115-122.
95. Vrieling C., Collette L., Fourquet A., Hoogenraad W.J., Horiot J.H., Jager J.J., et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC "boost vs. no boost" trial. Radiother Oncol 2000, 55:219-232.
96. Cochrane R.A., Valasiadou P., Wilson A.R., Al-Ghazal S.K., Macmillan R.D. Cosmesis and satisfaction after breast-conserving surgery correlates with percentage of breast volume excised. Br J Surg 2003, 90:1505-1509.
97. Bartelink H., Horiot J.C., Poortmans P., Struikmans H., Van den Bogaert W., Barillot I., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001, 345:1378-1387.
98. Stroom J., Schlief A., Alderliesten T., Peterse H., Bartelink H., Gilhuijs K. Using histopathology breast cancer data to reduce clinical target volume margins at radiotherapy. Int J Radiat Oncol Biol Phys 2009, 74:898-905.
99. van Loon J., Siedschlag C., Stroom J., Blauwgeers H., van Suylen R.J., Knegjens J., et al. Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features. Int J Radiat Oncol Biol Phys 2012, 82:448-456.
100. Rosenstein B.S., Lymberis S.C., Formenti S.C. Biologic comparison of partial breast irradiation protocols. Int J Radiat Oncol Biol Phys 2004, 60:1393-1404.
101. Probst H., Griffiths S. Moving to a high-tech approach to the irradiation of early breast cancer: is it possible to balance efficacy, morbidity and resource use?. Clin Oncol 2006, 18:268-275.
102. Trakul N., Chang C.N., Harris J., Chapman C., Rao A., Shen J., et al. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors. Int J Radiat Oncol Biol Phys 2012, 84(1):231-237.
103. Greco C., Zelefsky M.J., Lovelock M., Fuks Z., Hunt M., Rosenzweig K., et al. Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. Int J Radiat Oncol Biol Phys 2011, 79:1151-1157.
104. Shah C., Wilkinson J.B., Shaitelman S., Grills I., Wallace M., Mitchell C., et al. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma. Int J Radiat Oncol Biol Phys 2011, 81:e547-e551.
105. Vicini F.A., Chen P., Wallace M., Mitchell C., Hasan Y., Grills I., et al. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2007, 69:1124-1130.
106. Bentzen S.M., Yarnold J.R. Reports of unexpected late side effects of accelerated partial breast irradiation-radiobiological considerations. Int J Radiat Oncol Biol Phys 2010, 77:969-973.
107. Jagsi R., Ben-David M.A., Moran J.M., Marsh R.B., Griffith K.A., Hayman J.A., et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 2010, 76:71-78.
108. Hepel J.T., Tokita M., MacAusland S.G., Evans S.B., Hiatt J.R., Price L.L., et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2009, 75:1290-1296.
109. Recht A., Ancukiewicz M., Alm El-Din M.A., Lu X.Q., Martin C., Berman S.M., et al. Lung dose-volume parameters and the risk of pneumonitis for patients treated with accelerated partial-breast irradiation using three-dimensional conformal radiotherapy. J Clin Oncol 2009, 27:3887-3893.
110. Moser E.C., Noordijk E.M., van Glabbeke M., Teodorovic I., de Wolf-Peeters C., Carde P., et al. Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trials. Eur J Cancer 2004, 40:474-480.
111. Dodwell D.J., Dyker K., Brown J., Hawkins K., Cohen D., Stead M., et al. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol 2005, 17:618-622.
112. Ribeiro G.G., Magee B., Swindell R., Harris M., Banerjee S.S. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol 1993, 5:278-283.
113. Polgár C., Fodor J., Major T., Németh G., Lövey K., Orosz Z., et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast cancer - 5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 2007, 69:694-702.
114. Valachis A., Mauri D., Polyzos N.P., Mavroudis D., Georgoulias V., Casazza G. Partial breast irradiation or whole breast radiotherapy for early breast cancer: a meta-analysis of randomized controlled trials. Breast J 2010, 16:245-251.
115. Ontario Clinical Oncology Group, Canadian Institutes of Health Research, Canadian Breast Cancer Research Alliance. RAPID: randomized trial of accelerated partial breast irradiation. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00282035.
116. Strnad V, Polgár C; on behalf of the European Brachytherapy Breast Cancer GEC-ESTRO Working Group. Phase III multicenter trial. Interstitial brachytherapy alone versus external beam radiation therapy after breast conserving surgery for low risk invasive carcinoma and low risk duct carcinoma in-situ (DCIS) of the female breast. Available from: http://www.apbi.uni-erlangen.de.
117. Yarnold J, Coles C; on behalf of the IMPORT LOW Trial Management Group. Intensity modulated and partial organ radiotherapy. Randomised trial testing intensity modulated and partial organ radiotherapy following breast conservation surgery for early breast cancer. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00814567.
118. Orecchia R., Ciocca M., Tosi G., Franzetti S., Luini A., Gatti G., et al. Intraoperative electron beam radiotherapy (ELIOT) to the breast: a need for a quality assurance programme. Breast 2005, 14:541-546.
119. Armaroli L, Barbieri E, Bertoni F, Busutti L, Cardinali M, Cartei F, et al. Breast cancer with low risk of local recurrence: partial and accelerated radiation with three-dimensional conformal radiotherapy (3DCRT) vs. standard radiotherapy after conserving surgery (phase III study). Version 01.05 2007. Available from: http://groups.eortc.be/radio/res/irma/synopsis_trial_irma1.pdf.
120. Belkacemi Y, Lartigau E, Bourgier C. Standard of hypofractionated radiotherapy versus accelerated partial breast irradiation (APBI) for breast cancer (SHARE). Available from: http://www.clinicaltrials.gov/ct2/show/NCT01247233%3fterm%3dAPBI+SHARE%26rank%3d1.
121. Orecchia R., Leonardi M.C. IORT update: what are the limits of total dose and volume?. Radiother Oncol 2012, 103. SP-0097.
122. Mammosite: targeted radiation therapy. Available at: [accessed 15.08.12]. http://www.mammosite.com/physicians.
123. Vicini F., Arthur D., Wazer D., Chen P., Mitchell C., Wallace M., et al. Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2011, 79:977-984.
124. Wilkinson J.B., Reid R.E., Shaitelman S.F., Chen P.Y., Mitchell C.K., Wallace M.F., et al. Outcomes of breast cancer patients with triple negative receptor status treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2011, 81:e159-e164.
125. Shah C., Antonucci J.V., Wilkinson J.B., Wallace M., Ghilezan M., Chen P., et al. Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis. Radiother Oncol 2011, 100:210-214.
126. McHaffie D.R., Patel R.R., Adkison J.B., Das R.K., Geye H.M., Cannon G.M. Outcomes after accelerated partial breast irradiation in patients with ASTRO consensus statement cautionary features. Int J Radiat Oncol Biol Phys 2011, 81:46-51.
127. Leonardi M.C., Maisonneuve P., Mastropasqua M.G., Morra A., Lazzari R., Rotmensz N., et al. How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys 2012, 83:806-813.
128. Husain Z.A., Mahmood U., Hanlon A., Neuner G., Buras R., Tkaczuk K., et al. Accelerated partial breast irradiation via brachytherapy: a patterns-of-care analysis with ASTRO consensus statement groupings. Brachytherapy 2011, 10:479-485.
129. Mannino M., Yarnold J. Accelerated partial breast irradiation trials: diversity in rationale and design. Radiother Oncol 2009, 91:16-22.
130. Smith GL, Xu Y, Buchholz TA, Giordano SH, Smith BD. Partial breast brachytherapy is associated with inferior effectiveness and increased toxicity compared with whole-breast irradiation in older patients. In: 34th Annual San Antonio Breast Cancer Symposium (SABCS); 2011. Abstract S2-1.
131. Smith G.L., Xu Y., Buchholz T.A., Giordano S.H., Jiang J., Shih Y.C., et al. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA 2012, 307:1827-1837.